Immune modulating effects of poly ICLC.
D000276:Adjuvants, Immunologic; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D000914:Antibodies, Viral / Q000096:biosynthesis; D002266:Carboxymethylcellulose Sodium / Q000494:pharmacology* / Q000031:analogs & derivatives; D006193:Haemophilus influenzae / Q000276:immunology; D006801:Humans; D007109:Immunity / Q000187:drug effects*; D007252:Influenza Vaccines / Q000008:administration & dosage; D008214:Lymphocytes / Q000276:immunology; D008253:Macaca mulatta; D008747:Methylcellulose / Q000031:analogs & derivatives*; D051379:Mice; D010455:Peptides / Q000494:pharmacology*; D011070:Poly I-C / Q000494:pharmacology*; D011107:Polylysine / Q000494:pharmacology* / Q000031:analogs & derivatives; D051381:Rats
D000276:Adjuvants, Immunologic; D000907:Antibodies, Bacterial; D000914:Antibodies, Viral; D007252:Influenza Vaccines; D010455:Peptides; D011107:Polylysine; C019531:poly ICLC; D008747:Methylcellulose; D002266:Carboxymethylcellulose Sodium; D011070:Poly I-C